Abstract:Aim: To detect the level of thyroid hormone in patients with major depressive disorder and dysthymic disorder, and observe the biological significance of neuroendocrine changes in the patients with major depressive disorder and dysthymic disorder. Methods: Inpatients with major depressive disorder (n=30) and dysthymic disorder (n=30) were selected from the outpatient departments of psychiatry and neurology and the third inpatient division of the Department of Psychiatry, the First Clinical Hospital of Harbin Medical University, and Harbin First Specific Hospital between January and December 2004. They were assessed with Hamilton depression scale (HAMD), Eysenck personality questionnaire (EPQ) and life event scale (LES). The serum levels of 3,5,3-triiodothyronine (T 3), 3,5,3,5,-tetraiodotyyronine (T 4) and thyroid stimulating hormone (TSH) were determined with radioimmunoassay in both groups. Results: All the 30 patients with major depressive disorder and 30 patients with dysthymic disorder entered the analysis of results. 1 The total score of HAMD had completely significant difference between the groups (P=0.000), and there were significant differences in the factor scores of anxiety/somatization, cognitive impairment and retardation, and the neural scale in EPQ (P < 0.05). 2 The T 4 level was significantly different between the two groups. 3 In the patients with major depressive disorder, the T 3 level was positively correlated with the score of extraversion-introversion in EQP and the score of retardation in HAMD (r=0.0411, 0.426, P=0.024, 0.019); T 4 level was positively correlated with the total score of HAMD, score of anxiety, and the stimulative amount of negative life events (r=0.474, 0.416, 0.426, P=0.015, 0.022, 0.019); TSH was positively correlated with the stimulative amount of positive life events (r=0.433, P=0.017). In the patients with dysthymic disorder, T 3 level was negative correlated with the score of cognitive impairment (r=-0.509, P=0.004); T 4 level had positive correlation with the total score of HAMD, stimulative amount of negative life events and score of retardation (r=0.396, 0.420, 0.367, P=0.042, 0.021, 0.046). Conclusion: Negative life events accelerate the episode of depression, and T 4 level could be a useful predictor for the severity of depressive symptoms.

Exploring the potential of thyroid hormones to predict clinical improvements in depressive patients: A machine learning analysis of the real-world based study.

Potential Biomarkers for Predicting of Depression in Diabetes Mellitus

Predicting acupuncture efficacy for major depressive disorder using baseline clinical variables: A machine learning study

The research about changes of thyroid function in patients with depression

The Relevant Research of Thyroid Hormones and Clinical Features in Treatment-Resistant Depression

Predicting plasma concentration of quetiapine in patients with depression using machine learning techniques based on real-world evidence

Comparison of the level of thyroid hormones between patients with major depressive disorder and dysthymic disorder

Predicting Elevated TSH Levels in the Physical Examination Population With a Machine Learning Model

Association between thyroid dysfunction, metabolic disturbances, and clinical symptoms in first-episode, untreated Chinese patients with major depressive disorder: Undirected and Bayesian network analyses

Association Between Thyroid Hormones and Comorbid Psychotic Symptoms in Patients with First-Episode and Drug-Naïve Major Depressive Disorder.

Development of Machine-Learning-driven Signatures for Diagnosing and Monitoring Therapeutic Response in Major Depressive Disorder Using Integrated Immune Cell Profiles and Plasma Cytokines

Comparison of Thyroid Hormone Levels Between Patients With Major Depressive Disorder and Healthy Individuals in China

Association between thyroid function and major depression

The changes of thyroid hormone level in readmission patients with depressive disorder

Relationship between thyroid-stimulating hormone and blood lipids in patients with first-episode depression

The association between depression and thyroid function

Clinical correlates of autoimmune thyroiditis and non-autoimmune hypothyroidism in treatment-naïve patients with major depressive disorders

Using an Interpretable Amino Acid-Based Machine Learning Method to Enhance the Diagnosis of Major Depressive Disorder

Association Between Thyroid Function and Psychotic Symptoms in Adolescents with Major Depressive Disorder: A Large Sample Sized Cross-Sectional Study in China

In perspective of specific symptoms of major depressive disorder: Functional connectivity analysis of electroencephalography and potential biomarkers of treatment response

The effect of thyroid function on the risk of psychiatric readmission after hospitalization for major depressive disorder